Concepedia
Statistics
Publications
26
Citations
1.8K
H-Index
20
Active since
1989
Affiliations
Pfizer (United Kingdom)(Current)
Pfizer (United States)
University of Alabama at Birmingham
Pfizer (Canada)
University of Cambridge
Peter T. Loudon is an author at Pfizer (United Kingdom) specializing in immunology, immunization, and vaccination.
Publications per year
1989–2023
Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration
Lyndon da Cruz, Kate Fynes, Odysseas Georgiadis et al. · Nature Biotechnology · 2018 · 720 citations
Medicine, Cell Biology, Ophthalmology +17
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial
Suzanne Jones, Kirsten Evans, Hilary McElwaine-Johnn et al. · Vaccine · 2009 · 140 citations
Veterinary Medicine, Immunology, Infectious Diseases +17
Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy
E.A. Hewat, Timothy F. Booth, Peter T. Loudon et al. · Virology · 1992 · 103 citations
Life Sciences, Biology, Microbiology +16
HERV-K–specific T cells eliminate diverse HIV-1/2 and SIV primary isolates
R. Brad Jones, Keith Garrison, Shariq Mujib et al. · Journal of Clinical Investigation · 2012 · 95 citations
Life Sciences, Immunology, Molecular Biology +17
GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates
Peter T. Loudon, Eric J. Yager, Debbie T. Lynch et al. · PLoS ONE · 2010 · 77 citations · Full text
Pharmacy, Immunology, Infectious Diseases +17
1–5 of 26